PD-L1 expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI) and nivo alone in advanced melanoma (MEL): A pooled analysis Meeting Abstract
| Authors: | Long, G.; Larkin, J.; Ascierto, P.; Hodi, S.; Rutkowski, P.; Chiarion-Selini, V.; Hassel, J.; Lebbe, C.; Pavlick, A.; Wagstaff, J.; Schadendorf, D.; Dummer, R.; Hogg, D.; Haanen, J.; Corrie, P.; Hoeller, C.; Horak, C.; Wolchok, J.; Robert, C. |
| Abstract Title: | PD-L1 expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI) and nivo alone in advanced melanoma (MEL): A pooled analysis |
| Meeting Title: | COSA's 43rd Annual Scientific Meeting |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 12 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2016 Nov 15-17 |
| Meeting Location: | Queensland, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2016-11-01 |
| Start Page: | 126 |
| Language: | English |
| ACCESSION: | WOS:000387769900189 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.12646 |
| Notes: | Meeting Abstract: 240 -- Source: Wos |
